| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 111.816 | 3.307 | 6.374 | 11.198 | 84 | 3.614 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 112.561 | 3.338 | 6.383 | 11.242 | 110 | 3.614 | 0 | 10 | 122 | 88 |
| Total Expenses - EUR | 96.861 | 5.317 | 7.535 | 9.574 | 2.197 | 1.812 | 760 | 734 | 96 | 187 |
| Gross Profit/Loss - EUR | 15.701 | -1.979 | -1.152 | 1.668 | -2.087 | 1.802 | -760 | -724 | 26 | -99 |
| Net Profit/Loss - EUR | 13.166 | -1.979 | -1.193 | 1.330 | -2.090 | 1.705 | -760 | -724 | 22 | -99 |
| Employees | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biotools S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.290 | 1.662 | 1.040 | 438 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 21.172 | 18.472 | 17.070 | 18.672 | 16.652 | 18.037 | 16.879 | 4.476 | 4.128 | 4.004 |
| Inventories | 273 | 268 | 264 | 252 | 248 | 243 | -8 | 0 | 0 | 0 |
| Receivables | 1.921 | 2.799 | 266 | 162 | 514 | 515 | 548 | 288 | 287 | 286 |
| Cash | 18.978 | 15.405 | 16.541 | 18.257 | 15.891 | 17.279 | 16.339 | 4.188 | 3.840 | 3.718 |
| Shareholders Funds | 21.838 | 19.636 | 18.110 | 19.108 | 16.648 | 18.037 | 16.877 | 4.507 | 4.123 | 4.001 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.624 | 499 | 0 | 1 | 5 | 0 | 2 | -31 | 4 | 2 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Biotools S.r.l.